» Articles » PMID: 9307530

Conservative Surgery for Stage I Ovarian Carcinoma in Women of Childbearing Age

Overview
Date 1997 Oct 6
PMID 9307530
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the results of a policy of tailored conservative surgical management for young women with stage I ovarian carcinomas.

Design: Retrospective study.

Participants: Ninety-nine women aged 40 years or younger who underwent either primary surgery in our department or were referred after primary surgery performed elsewhere.

Methods: Of the 99 women in our study, 56 underwent fertility-sparing surgery and 43 more radical surgery. Minimal requirements for conservative management were adequate staging and complete information about the therapeutic options. Factors important in the choice of the treatment were, age, wish to preserve fertility, histologic type and grade, and the stage of the tumour.

Results: Conservative treatment was conducted in 84% of nulliparous and in 33% of parous women; 62% of grade 1 tumours, 48% of grade 2, and 50% of grade 3 were treated conservatively. With a median follow up of seven years, we observed five recurrences (9%) of carcinoma in women treated conservatively and five (12%) in those treated more radically. Two women (one in each treatment arm) were saved after recurrence. Two recurrences after conservative surgery involved the residual ovary (3.6%). Two women developed borderline tumour in the contralateral ovary and both were treated by surgery.

Conclusion: After adequate staging and accurate information is given to the patient, conservative treatment may be safe in some women with early ovarian cancer. The risk of recurrence in the contralateral ovary is low. Conservative surgery may be also considered in some Stage I grade 3 tumours and in some women with stage JC tumours.

Citing Articles

Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.

Berek J, Renz M, Kehoe S, Kumar L, Friedlander M Int J Gynaecol Obstet. 2021; 155 Suppl 1:61-85.

PMID: 34669199 PMC: 9298325. DOI: 10.1002/ijgo.13878.


Fertility-Sparing Surgery for Ovarian Cancer.

Canlorbe G, Chabbert-Buffet N, Uzan C J Clin Med. 2021; 10(18).

PMID: 34575345 PMC: 8466872. DOI: 10.3390/jcm10184235.


Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution.

Baek M, Park J, Kim D, Suh D, Kim J, Kim Y J Gynecol Oncol. 2020; 31(6):e85.

PMID: 33078594 PMC: 7593218. DOI: 10.3802/jgo.2020.31.e85.


A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women.

Johansen G, Dahm-Kahler P, Staf C, Radestad A, Rodriguez-Wallberg K BMC Cancer. 2020; 20(1):1009.

PMID: 33076846 PMC: 7574478. DOI: 10.1186/s12885-020-07511-y.


Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival.

Liu D, Cai J, Gao A, Wang Z, Cai L BMC Cancer. 2020; 20(1):320.

PMID: 32293358 PMC: 7161302. DOI: 10.1186/s12885-020-06828-y.